ADHD Medication Exposure During Pregnancy Does Not Affect Offspring Long-Term
A recent study published in Molecular Psychiatry has found that exposure to attention-deficit/hyperactivity disorder (ADHD) medication during pregnancy does not negatively impact neurodevelopment and growth in offspring. The study, conducted by researchers at Aarhus University in Denmark, analyzed 898 children who were exposed to ADHD medication in utero and 1,270 children whose mothers discontinued ADHD medication before pregnancy. The children were born between 1998 and 2015 and followed through 2018.
After adjusting for demographic and psychiatric characteristics of the mother, the researchers found no increased risk for any developmental disorders in the offspring. The study’s co-author emphasized the importance of gaining more knowledge about the effects of ADHD medication during pregnancy to help women make informed decisions. However, several authors of the study disclosed financial ties to the pharmaceutical industry.